The company is the national priority chinese pharmaceutical firm, the national priority high-technology company, the national innovation pilot enterprise, the national central engineering unit of the national central medicine administration, the national enterprise technology centre, the national intellectual property demonstration enterprise, the national stock a listing company, the hunan province industrial quality standard demonstration company, the first changsha city mayor quality award-winning enterprise, and the national post-doctoral research station. The birthplace of the former `lau 9' was seven years old, 1650 a. D. In 2000, kowloon was placed on the market, stock code 000989. In september 2006, the “sixty-christ” was designated by the state department of commerce as the “old chinese character”; in june 2008, the traditional chinese medicine culture was included in the national inventory of intangible cultural heritage. Over the years, kyushu chi chi chi chi-chon has been developing innovatively and innovatively, and has now become a 30-plus molecular company with more than 500 chained shops that combine production, marketing, scientific research and health management. By the end of 2021, the company's total assets amounted to $5,266 million, net assets to $3,969 million and brand value to $10,316 million. By 2021, the company had earned $3,784 million in operating income, an increase of 631 per cent over the same period, net profits of $271 million, which was essentially the same as the previous year, and tax payments totalled 422 million in 2021. In the 2021 china brand value evaluation information release, nine cheetsa was ranked at the top of the “china olds” list, with over billions of brand values. The company has chinese medicine, precious tablets, biopharmaceuticals, great health series products, which form the core-driven engine of development in areas such as amphibious injection fluids, assemblage granules, six-sortice yellowballs, glues, cervix yellowballs, permafrosts, retorts, nudity purple tablets, skikon, etc., which cover the heart and brain vessels, kidneys, blood supplements, women and children, and five official subjects, with the full range and life cycle of safeguarding public health. In parallel with the steady development of the main industry, the new chain of medical facilities has been actively developed, and the kyushu health building in changsha has been successfully approved as the country's first model site for chinese medicine and health tourism, moving from a focus on pharmaceuticals to cultural heritage. As part of its mission to provide health services for the whole of the human life cycle, the nine departments are committed to implementing the concept of development of "combining inheritance and innovation", integrating traditional medicine with precision medicine, advancing into the field of biomedicine and regenerative medicine, working to provide accurate and effective services for the management of health throughout the life cycle in the areas of prevention, treatment and rehabilitation, using the area of general health as the starting point and setting point for the next nine。